Products from ViroCyt, now part of Sartorius Stedim Biotech, are leading the field of rapid virus quantification. Our goal is to provide the tools that deliver meaningful improvements to mission critical processes, where viruses play a significant role.
∨ Vaccine production ∨ Protein expression ∨ Viral therapeutics ∨ Antiviral development
Our virus quantification products offer a new approach to enable direct, biologically-specific quantification of viruses in minutes, rather than the days or weeks required by more traditional methods. Virus samples are labeled with specifically-developed reagents in a no-wash assay. The purpose-build platform enables quantification of total virus particles in three minutes per the sample, giving users real-time insights into viral titers.
Meet The Virus Counter Platform: The Powerful Tool for Rapid Virus Quantification
The Virus Counter® Platform is in use by leading companies, regulatory agencies, and research agencies around the world. Why? A growing body of evidence demonstrates that noninfective particles are of biological importance and can impact both in vitro and in vivo studies. Infectivity and total particle concentration are essential for an in-depth sample characterization.
Vaccine Process Development and Manufacturing
Racing for a Viable Vaccine: Expediting Vaccine Development Amidst a Pandemic
싸토리우스코리아 웹사이트는 귀하의 사용자 경험을 개선하고 귀하의 관심사에 맞는 콘텐츠를 제공하기 위해 쿠키를 사용합니다.
본인은 Sartorius가 사용자 프로필을 생성하고 관심있는 관련 있는 광고를 제공하기 위해 본인과 관련된 데이터를 처리하는 데 동의합니다.
이 동의는 자발적이며 이 웹사이트를 사용하는데 필요하지 않으며 향후 언제든지 철회할 수 있습니다.